Literature DB >> 28937268

Real-time intraprocedural 18F-FDG PET/CT-guided biopsy using automated robopsy arm (ARA) in the diagnostic evaluation of thoracic lesions with prior inconclusive biopsy results: initial experience from a tertiary health care centre.

Renjith Kalathoorakathu Radhakrishnan1, Bhagwant Rai Mittal1, Arun Kumar Reddy Gorla1, Rajender Kumar Basher1, Ashwani Sood1, Amanjit Bal2, Naveen Kalra3, Niranjan Khandelwal3, Navneet Singh4, Digambar Behera4.   

Abstract

OBJECTIVE: The aim of this study was to assess the feasibility and appraise the diagnostic utility of real time 18F-FDG PET/CT-guided biopsy under automated robopsy arm (ARA) guidance for the evaluation of thoracic lesions with prior inconclusive biopsy results.
METHODS: PET/CT-guided biopsy of thoracic lesions was performed in patients who had at least one previous inconclusive biopsy. A total of 25 patients (male:female-18 males, 7 females; age: range, 13-75; mean, 53.7) were included in this study. All these patients underwent percutaneous needle biopsies under real-time PET/CT guidance using ARA (ROBIO-EX, Perfint healthcare Pvt Ltd, Chennai, India) needle navigation technique. Histopathology and clinical follow-up results were reviewed for assessing the accuracy of procedures.
RESULTS: Adequate representative tissue sample could be retrieved in all the patients. No major procedure-related complications were encountered in any patient. Of the 25 procedures, 21 lesions were positive for malignancy and benign findings were observed in the other 4 lesions on histopathology. None of the patients required further biopsy in arriving at a final diagnosis. Overall diagnostic yield of the procedure was 100%.
CONCLUSION: Real time 18F-FDG PET/CT guidance for percutaneous biopsies of lung and mediastinal lesions is a feasible technique with potential utility in patients with previous inconclusive biopsy results. Advances in knowledge: 18F-FDG PET/CT guidance reduces the sampling errors by specifically targeting areas of viability and avoiding necrosis/atelectasis. A navigational tool like ARA is thought to help in accurately targeting these areas.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28937268      PMCID: PMC6047647          DOI: 10.1259/bjr.20170258

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  32 in total

Review 1.  Navigational Tools for Interventional Radiology and Interventional Oncology Applications.

Authors:  Monzer A Chehab; Waleed Brinjikji; Alexander Copelan; Aradhana M Venkatesan
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Comparison of CT-guided percutaneous biopsy with and without registration of prior PET/CT images to diagnose mediastinal tumors.

Authors:  Koichi Yokoyama; Osamu Ikeda; Koichi Kawanaka; Yutaka Nakasone; Yoshitaka Tamura; Seijiro Inoue; Fumi Sakamoto; Morikatsu Yoshida; Shinya Shiraishi; Yasuyuki Yamashita
Journal:  Cardiovasc Intervent Radiol       Date:  2013-11-22       Impact factor: 2.740

3.  Image-guided biopsy: what the interventional radiologist needs to know about PET/CT.

Authors:  Katsuhiro Kobayashi; Peeyush Bhargava; Shanker Raja; Farbod Nasseri; Hassan A Al-Balas; Darryl D Smith; Sharad P George; Meena S Vij
Journal:  Radiographics       Date:  2012 Sep-Oct       Impact factor: 5.333

4.  Results and complications of CT-guided transthoracic fine-needle aspiration biopsy of pulmonary lesions.

Authors:  Cristiano Dias de Lima; Rodolfo Acatauassu Nunes; Eduardo Haruo Saito; Cláudio Higa; Zanier José Fernando Cardona; Denise Barbosa dos Santos
Journal:  J Bras Pneumol       Date:  2011 Mar-Apr       Impact factor: 2.624

Review 5.  Low-dose techniques in CT-guided interventions.

Authors:  Marc Sarti; William P Brehmer; Spencer B Gay
Journal:  Radiographics       Date:  2012 Jul-Aug       Impact factor: 5.333

Review 6.  Fluorodeoxyglucose-PET/Computed Tomography-Guided Biopsy.

Authors:  Juliano J Cerci; Elena Tabacchi; Mateos Bogoni
Journal:  PET Clin       Date:  2015-09-28

7.  18F-FDG PET/CT-directed biopsy: does it offer incremental benefit?

Authors:  Nilendu C Purandare; Aniruddha V Kulkarni; Suyash S Kulkarni; Diptiman Roy; Archi Agrawal; Sneha Shah; Venkatesh Rangarajan
Journal:  Nucl Med Commun       Date:  2013-03       Impact factor: 1.690

8.  Diagnostic accuracy of image-guided percutaneous fine needle aspiration biopsy of the mediastinum.

Authors:  Margaret W Assaad; Liron Pantanowitz; Christopher N Otis
Journal:  Diagn Cytopathol       Date:  2007-11       Impact factor: 1.582

Review 9.  [Basic concepts on 18F-FDG PET/CT: definitions and normal variants].

Authors:  Ernesto Roldán-Valadez; Iván Vega-González; Guillermo Valdivieso-Cárdenas; Alfonso Rumoroso-García; Osvaldo Morales-Santillán; Luis Osorio-Cardiel
Journal:  Gac Med Mex       Date:  2008 Mar-Apr       Impact factor: 0.302

10.  Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities.

Authors:  F Cornelis; M Silk; H Schoder; H Takaki; J C Durack; J P Erinjeri; C T Sofocleous; R H Siegelbaum; M Maybody; S B Solomon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-09       Impact factor: 9.236

View more
  3 in total

1.  Comparison Between CBCT and Fusion PET/CT-CBCT Guidance for Lung Biopsies.

Authors:  Federico Fontana; Filippo Piacentino; Anna Maria Ierardi; Gianpaolo Carrafiello; Andrea Coppola; Alessandra Muollo; Alessandro Beneventi; Chiara Floridi; Andrea Selenito Imperatori; Giulio Carcano; Massimo Venturini
Journal:  Cardiovasc Intervent Radiol       Date:  2020-09-07       Impact factor: 2.740

2.  Diagnostic performance of real-time robotic arm-assisted 18F-FDG PET/CT-guided percutaneous biopsy in metabolically active abdominal and pelvic lesions.

Authors:  Rajender Kumar; Bhagwant Rai Mittal; Anish Bhattacharya; Harmandeep Singh; Amanjit Bal; Shelvin Kumar Vadi; Ashwani Sood; Gaurav Prakash; Harjeet Singh; Aman Sharma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-30       Impact factor: 9.236

3.  Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [18F]FDG PET/CT.

Authors:  Felipe Montes de Jesus; V Vergote; W Noordzij; D Dierickx; R A J O Dierckx; A Diepstra; T Tousseyn; O Gheysens; T C Kwee; C M Deroose; A W J M Glaudemans
Journal:  J Clin Med       Date:  2021-01-19       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.